ADMET-Evaluation, Pharmacokinetics, Drug-likeness and Medicinal Chemistry of GCMS Identified Bioactive Compounds of Moringa oleifera Natural-Ripened-Dried Methanolic Pod Extract (MOMPE) as a Potential Source of Natural Drug Frontrunner for Next Generation
Over centuries, Moringa oleifera has been used as an integral part of Ayurveda, Siddha and Unani systems of medicine, besides this miracle tree has a wide range of nutritional and bioactive compounds, including proteins, essential amino acids, carbohydrates, lipids, fiber, vitamins, minerals, phenolic compounds, phytosterols and others. The miracle tree is endowed with a wide range of pharmacological properties, including anti-diabetic, anti-inflammatory, anti-carcinogenic, antioxidant, cardioprotective, antimicrobial and hepatoprotective activities. However, deeper dimensions of authentic data on plant based natural products in relation to drug discovery, pharmacokinetics properties of biomolecules is far lacking. ADMET prospecting is eventually expected to contribute to success of MO based lead candidates in drug design, development program besides saving time and money. This study is the first of its kind reporting summative ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicology) properties of all bioactive compounds Moringa oleifera methanolic pod extract (MOMPE) as a potential source of natural drug lead using Swiss ADME. A total of 12 compounds namely - 7-Octadecyne, 2-methyl- (C19H36); 3,7,11,15-Tetramethyl-2-hexadecen-1-ol (C20H40O); 3,7,11,15-Tetramethyl-2-hexadecen-1-ol (C20H40O); 6,9,12,15-Docosatetraenoic acid, me (C23H38O2); Cyclohexanol, 5-methyl-2-(1-methylethyl)- (C10H20O); 3,7,11,15-Tetramethyl-2-hexadecen-1-ol (C20H40O); Palmitic acid vinyl ester (C18H34O2); .γ.-Tocopherol (C28H48O2); Vitamin E (C29H50O2); Cholesta-7,9(11)-dien-3-ol, 4,4-dim (C29H48O); γ.-Sitosterol (C29H50O); Stigmasta-5,24(28)-dien-3-ol, (3.β.,24Z)- (C29H48O). Most of the MOPBNPs are non-substrate for both P-gp (P-glycoprotein) and CYP (Cytochrome P-450 isoenzymes). All the compounds were evaluated for properties viz., GI absorption, BBB permeant, Pgp substrate, CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4 inhibitors, Lipinski, Ghose, Veber, Egan, Muegge, rule and Bioavailability Score to provide baseline information on PBNPs in MONRD pod.
Keywords: PBNPs; NGDDT; ADMET; Moringa oleifera; Secondary Metabolites MONRD pod
2. Sanjay P, Dwivedi KN. Shingru Moringa oleifera Lam.: A critical review. International Journal of Ayurveda and Pharmaceutical Chemistry. 2015; 3(1):217-27.
3. Sujatha BK, Patel P. Moringa oleifera-Nature's Gold. Imperial Journal of Interdisciplinary Research. 2017; 3(5):1175-9.
4. Meireles D, Gomes J, Lopes L, Hinzmann M, Machado J. A review of properties, nutritional and pharmaceutical applications of Moringa oleifera: integrative approach on conventional and traditional Asian medicine. Advances in Traditional Medicine. 2020 Dec; 20(4):495-515. https://doi.org/10.1007/s13596-020-00468-0
5. Dixit S, Tripathi A, Kumar P. Medicinal properties of Moringa oleifera: A review. International Journal of education and Science research review. 2016 Apr; 3(2):173-85.
6. Singh SK, Rajoria K, Kushal A, Dadhich S. Moringa oleifera lam. a drug with ayurvedic and biomedicine approaches. Journal of Ayurveda. 2021 Oct 1; 15(4):293. https://doi.org/10.4103/joa.joa_159_20
7. Mutheeswaran S, Pandikumar P, Chellappandian M, Ignacimuthu S. Documentation and quantitative analysis of the local knowledge on medicinal plants among traditional Siddha healers in Virudhunagar district of Tamil Nadu, India. Journal of Ethnopharmacology. 2011 Sep 1; 137(1):523-33. https://doi.org/10.1016/j.jep.2011.06.003
8. Kumar, P.; Singh, K.; Kumar, A. Hepatoprotective Studies on Aerial Parts of Moringa oleifera Lam. on Carbon tetrachloride induced liver cell damage in albino rats. Ann. Biol. Res. 2010; 1:27-35.
9. Kalaimathi RV, Krishnaveni K, Murugan M, Basha AN, Gilles AP, Kandeepan C, Senthilkumar N, Mathialagan B, Ramya S, Ramanathan L, Jayakumararaj R. ADMET informatics of Tetradecanoic acid (Myristic Acid) from ethyl acetate fraction of Moringa oleifera leaves. Journal of Drug Delivery and Therapeutics. 2022; 12(4-S):101-11. https://doi.org/10.22270/jddt.v12i4-S.5533
10. Meena R, Prajapati SK, Nagar R, Porwal O, Nagar T, Tilak VK, Jayakumararaj R, Arya RK, Dhakar RC. Application of Moringa oleifera in Dentistry. Asian Journal of Dental and Health Sciences. 2021; 1(1):10-3. https://orcid.org/0000-0001-8250-8489
11. Kandeepan C, Sabitha M, Parvathi K, Senthilkumar N, Ramya S, Boopathi NM, Jayakumararaj R. Phytochemical Screening, GCMS Profile, and In-silico properties of Bioactive Compounds in Methanolic Leaf Extracts of Moringa oleifera. Journal of Drug Delivery and Therapeutics. 2022; 12(2):87-99. https://doi.org/10.22270/jddt.v12i2.5250
12. Murugan M, Krishnaveni K, Sabitha M, Kandeepan C, Senthilkumar N, Loganathan T, Pushpalatha GL, Pandiarajan G, Ramya S, Jayakumararaj R. In silico Target Class Prediction and Probabilities for Plant Derived Omega 3 Fatty Acid from Ethyl Acetate Fraction of Moringa oleifera Leaf Extract. Journal of Drug Delivery and Therapeutics. 2022; 12(3):124-37. https://doi.org/10.22270/jddt.v12i3.5352
13. Parvathi K, Kandeepan C, Sabitha M, Senthilkumar N, Ramya S, Boopathi NM, Ramanathan L, Jayakumararaj R. In-silico Absorption, Distribution, Metabolism, Elimination and Toxicity profile of 9, 12, 15-Octadecatrienoic acid (ODA) from Moringa oleifera. Journal of Drug Delivery and Therapeutics. 2022; 12(2-S):142-50. https://doi.org/10.22270/jddt.v12i2-S.5289
14. Suganandam K, Jeevalatha A, Kandeepan C, Kavitha N, Senthilkumar N, Sutha S, Seyed MA, Gandhi S, Ramya S, Grace Lydial Pushpalatha G, Abraham GC, Jayakumararaj R, Profile of Phytochemicals and GCMS Analysis of Bioactive Compounds in Natural Dried-Seed Removed Ripened Pods Methanolic Extracts of Moringa oleifera, Journal of Drug Delivery and Therapeutics. 2022; 12(5-S):133-141 https://doi.org/10.22270/jddt.v12i5-S.5657
15. Ghimire S, Subedi L, Acharya N, Gaire BP. Moringa oleifera: A Tree of Life as a Promising Medicinal Plant for Neurodegenerative Diseases. Journal of Agricultural and Food Chemistry. 2021 Nov 29; 69(48):14358-71. https://doi.org/10.1021/acs.jafc.1c04581
16. Abdull Razis AF, Ibrahim MD, Kntayya SB. Health benefits of Moringa oleifera. Asian pacific journal of cancer prevention. 2014; 15(20):8571-6. https://doi.org/10.7314/APJCP.2014.15.20.8571
17. Gallaher DD, Gallaher CM, Natukunda S, Schoenfuss TC, Mupere E, Cusick SE. Iron bioavailability from Moringa oleifera leaves is very low. The FASEB Journal. 2017 Apr; 31:786-13.
18. Azlan UK, Mediani A, Rohani ER, Tong X, Han R, Misnan NM, Jam FA, Bunawan H, Sarian MN, Hamezah HS. A Comprehensive Review with Updated Future Perspectives on the Ethnomedicinal and Pharmacological Aspects of Moringa oleifera. Molecules. 2022 Sep 6; 27(18):5765. https://doi.org/10.3390/molecules27185765
19. Tadele Y. Important anti-nutritional substances and inherent toxicants of feeds. Food science and quality management. 2015; 36:40-7.
20. Su B, Chen X. Current status and potential of Moringa oleifera leaf as an alternative protein source for animal feeds. Frontiers in veterinary science. 2020 Feb 26; 7:53. https://doi.org/10.3389/fvets.2020.00053
21. Wanjiru J, Gathirwa J, Sauli E, Swai HS. Formulation, Optimization, and Evaluation of Moringa oleifera Leaf Polyphenol-Loaded Phytosome Delivery System against Breast Cancer Cell Lines. Molecules. 2022 Jul 11; 27(14):4430. https://doi.org/10.3390/molecules27144430
22. Araújo LC, Aguiar JS, Napoleão TH, Mota FV, Barros AL, Moura MC, Coriolano MC, Coelho LC, Silva TG, Paiva PM. Evaluation of cytotoxic and anti-inflammatory activities of extracts and lectins from Moringa oleifera seeds. PloS one. 2013 Dec 9; 8(12):e81973. https://doi.org/10.1371/journal.pone.0081973
23. Saleem A, Saleem M, Akhtar MF, Ashraf Baig MM, Rasul A. HPLC analysis, cytotoxicity, and safety study of Moringa oleifera Lam.(wild type) leaf extract. Journal of Food Biochemistry. 2020 Oct; 44(10):e13400. https://doi.org/10.1111/jfbc.13400
24. Bayu F, Afework M, Geleta B, Ergete W, Makonnen E. Effect of chronic administration of aqueous leaves extract of Moringa stenopetala on blood parameters and histology of liver and kidney in rats. Ethiopian Journal of Health Sciences. 2020 Mar 1; 30(2). https://doi.org/10.4314/ejhs.v30i2.14
25. Elhassan M, Taha KK. Assessment of acute toxicity and LD50 of Moringa oleifera ethanolic leave extract in albino rats and rabbits. J. Med. Biol. Sci. Res. 2015 Jun; 1:38-43. 26. Ajayi TO, Moody JO, Akintayo CO. Toxicological evaluation of Moringa oleifera Lam seeds and leaves in Wistar rats. Pharmacogn. Commn. 2016; 6(2):100-11. https://doi.org/10.5530/pc.2016.2.8
27. Ramya S, Sutha S, Chandran M. Priyanka R, Loganathan T, Pandiarajan G, Kaliraj P, Grace Lydial Pushpalatha G, Abraham GC Jayakumararaj R, ADMET-informatics, Pharmacokinetics, Drug-likeness and Medicinal Chemistry of Bioactive Compounds of Physalis minima Ethanolic Leaf Extract (PMELE) as a Potential Source of Natural Lead Molecules for Next Generation Drug Design, Development and Therapies , Journal of Drug Delivery and Therapeutics. 2022; 12(5):188-200 https://doi.org/10.22270/jddt.v12i5.5654
28. Kalaimathi RV, Jeevalatha A, Basha AN, Kandeepan C, Ramya S, Loganathan T, Jayakumararaj R. In-silico Absorption, Distribution, Metabolism, Elimination and Toxicity profile of Isopulegol from Rosmarinus officinalis. Journal of Drug Delivery and Therapeutics. 2022; 12(1):102-8. https://doi.org/10.22270/jddt.v12i1.5188
29. Kandeepan C, Kalaimathi RV, Jeevalatha A, Basha AN, Ramya S, Jayakumararaj R. In-silico ADMET Pharmacoinformatics of Geraniol (3, 7-dimethylocta-trans-2, 6-dien-1-ol)-acyclic monoterpene alcohol drug from Leaf Essential Oil of Cymbopogon martinii from Sirumalai Hills (Eastern Ghats), INDIA. Journal of Drug Delivery and Therapeutics. 2021; 11(4-S):109-18. https://doi.org/10.22270/jddt.v11i4-S.4965
30. Krishnaveni K, Sabitha M, Murugan M, Kandeepan C, Ramya S, Loganathan T, Jayakumararaj R. vNN model cross validation towards Accuracy, Sensitivity, Specificity and kappa performance measures of β-caryophyllene using a restricted-unrestricted applicability domain on Artificial Intelligence & Machine Learning approach based in-silico prediction. Journal of Drug Delivery and Therapeutics. 2022; 12(1-S):123-31. https://doi.org/10.22270/jddt.v12i1-S.5222
31. Egan WJ, Merz KM, Baldwin JJ. Prediction of drug absorption using multivariate statistics. Journal of medicinal chemistry. 2000 Oct 19; 43(21):3867-77. https://doi.org/10.1021/jm000292e
32. Wessel MD, Jurs PC, Tolan JW, Muskal SM. Prediction of human intestinal absorption of drug compounds from molecular structure. Journal of Chemical Information and Computer Sciences. 1998 Jul 20; 38(4):726-35. https://doi.org/10.1021/ci980029a
33. Binkhathlan Z, Lavasanifar A. P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives. Current cancer drug targets. 2013 Mar 1; 13(3):326-46. https://doi.org/10.2174/15680096113139990076
34. Naef, R. (2015). A generally applicable computer algorithm based on the group additivity method for the calculation of seven molecular descriptors: heat of combustion, logPO/W, logS, refractivity, polarizability, toxicity and logBB of crganic compounds; scope and limits of applicability. Molecules 20:18279. https://doi.org/10.3390/molecules201018279
35. Elnaz Gozalpour, Rick Greupink, Heleen M. Wortelboer, Albert Bilos, Marieke Schreurs, Frans G. M. Russel, and Jan B. Koenderink . Interaction of Digitalis-Like Compounds with Liver Uptake Transporters NTCP, OATP1B1, and OATP1B3. Molecular Pharmaceutics 2014; 11(6):1844-1855. https://doi.org/10.1021/mp400699p
36. Motohashi H, Inui KI. Organic cation transporter OCTs (SLC22) and MATEs (SLC47) in the human kidney. The AAPS journal. 2013 Apr; 15(2):581-8. https://doi.org/10.1208/s12248-013-9465-7
37. Ekins S, Crumb WJ, Sarazan RD, Wikel JH, Wrighton SA. Three-dimensional quantitative structure-activity relationship for inhibition of human ether-a-go-go-related gene potassium channel. Journal of Pharmacology and Experimental Therapeutics. 2002 May 1; 301(2):427-34. https://doi.org/10.1124/jpet.301.2.427
38. Loganathan T, Barathinivas A, Soorya C, Balamurugan S, Nagajothi TG, Ramya S, Jayakumararaj R. Physicochemical, Druggable, ADMET Pharmacoinformatics and Therapeutic Potentials of Azadirachtin-a Prenol Lipid (Triterpenoid) from Seed Oil Extracts of Azadirachta indica A. Juss. Journal of Drug Delivery and Therapeutics. 2021; 11(5):33-46. https://doi.org/10.22270/jddt.v11i5.4981
39. Nazar S, Jeyaseelan M, Jayakumararaj R. Local Health Traditions, Cultural Reflections and Ethno-taxonomical Information on Wild Edible Fruit Yielding Medicinal Plants in Melur Region of Madurai District, TamilNadu, India. Journal of Drug Delivery and Therapeutics. 2022; 12(3):138-57. https://doi.org/10.22270/jddt.v12i3.5405
40. Rajasekaran C, Kalaivani T, Ramya S, Jayakumararaj R. Studies on hepatoprotective activity of ethanolic extracts of fruit pulp of Aegle marmelos (L.) Corr. Journal of Pharmacy Research. 2009; 2(9):1419-23.
41. Ramya S, Loganathan T, Chandran M, Priyanka R, Kavipriya K, Pushpalatha GG, Aruna D, Ramanathan L, Jayakumararaj R, Saluja V. Phytochemical Screening, GCMS, FTIR profile of Bioactive Natural Products in the methanolic extracts of Cuminum cyminum seeds and oil. Journal of Drug Delivery and Therapeutics. 2022; 12(2-S):110-8. https://doi.org/10.22270/jddt.v12i2-S.5280
42. Ramya S, Loganathan T, Chandran M, Priyanka R, Kavipriya K, Pushpalatha GL, Aruna D, Abraham GC, Jayakumararaj R. ADME-Tox profile of Cuminaldehyde (4-Isopropylbenzaldehyde) from Cuminum cyminum seeds for potential biomedical applications. Journal of Drug Delivery and Therapeutics. 2022; 12(2-S):127-41. https://doi.org/10.22270/jddt.v12i2-S.5286
43. Ramya S, Murugan M, Krishnaveni K, Sabitha M, Kandeepan C, Jayakumararaj R. In-silico ADMET profile of Ellagic Acid from Syzygium cumini: A Natural Biaryl Polyphenol with Therapeutic Potential to Overcome Diabetic Associated Vascular Complications. Journal of Drug Delivery and Therapeutics. 2022; 12(1):91-101. https://doi.org/10.22270/jddt.v12i1.5179
44. Ramya S, Neethirajan K, Jayakumararaj R. Profile of bioactive compounds in Syzygium cumini-a review. J. Pharm. Res. 2012; 5(8):4548-53.
45. Ramya S, Soorya C, Pushpalatha GG, Aruna D, Loganathan T, Balamurugan S, Abraham GC, Ponrathy T, Kandeepan C, Jayakumararaj R. Artificial Intelligence and Machine Learning approach based in-silico ADME-Tox and Pharmacokinetic Profile of α-Linolenic acid from Catharanthus roseus (L.) G. Don. Journal of Drug Delivery and Therapeutics. 2022; 12(2-S):96-109. https://doi.org/10.22270/jddt.v12i2-S.5274
46. Sabitha M, Krishnaveni K, Murugan M, Basha AN, Pallan GA, Kandeepan C, Ramya S, Jayakumararaj R. In-silico ADMET predicated Pharmacoinformatics of Quercetin-3-Galactoside, polyphenolic compound from Azadirachta indica, a sacred tree from Hill Temple in Alagarkovil Reserve Forest, Eastern Ghats, INDIA. Journal of Drug Delivery and Therapeutics. 2021; 11(5-S):77-84. https://doi.org/10.22270/jddt.v11i5-S.5026
47. Soorya C, Balamurugan S, Basha AN, Kandeepan C, Ramya S, Jayakumararaj R. Profile of Bioactive Phyto-compounds in Essential Oil of Cymbopogon martinii from Palani Hills, Western Ghats, INDIA. Journal of Drug Delivery and Therapeutics. 2021; 11(4):60-5. https://doi.org/10.22270/jddt.v11i4.4887
48. Soorya C, Balamurugan S, Ramya S, Neethirajan K, Kandeepan C, Jayakumararaj R. Physicochemical, ADMET and Druggable properties of Myricetin: A Key Flavonoid in Syzygium cumini that regulates metabolic inflammations. Journal of Drug Delivery and Therapeutics. 2021; 11(4):66-73. https://doi.org/10.22270/jddt.v11i4.4890
49. Vijaya V, Selvi BK, John PJ, Ramya S, Jayakumararaj R. Phytochemical Screening, GC-MS and FTIR analysis of Bioactive Compounds in Methanolic Leaf Extracts of Costus igneus (CIMLE) as a Natural Source of Drug Lead Molecules for Next-generation Drug-design, Development and Therapeutics. Journal of Drug Delivery and Therapeutics. 2022 Oct 17; 12(5-S):142-55. https://doi.org/10.22270/jddt.v12i5-S.5658
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).